- Home
- ISPR vs SLRN Comparison
ISPR vs SLRN Comparison
Compare ISPR & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- SLRN
- Stock Information
- Founded
- ISPR 2019
- SLRN 2020
- Country
- ISPR United States
- SLRN United States
- Employees
- ISPR N/A
- SLRN N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- ISPR Health Care
- SLRN Health Care
- Exchange
- ISPR Nasdaq
- SLRN Nasdaq
- Market Cap
- ISPR 286.1M
- SLRN 309.0M
- IPO Year
- ISPR 2023
- SLRN 2023
- Fundamental
- Price
- ISPR $4.55
- SLRN $1.99
- Analyst Decision
- ISPR Strong Buy
- SLRN Hold
- Analyst Count
- ISPR 1
- SLRN 5
- Target Price
- ISPR $12.50
- SLRN $9.60
- AVG Volume (30 Days)
- ISPR 74.9K
- SLRN 1.6M
- Earning Date
- ISPR 02-18-2025
- SLRN 11-13-2024
- Dividend Yield
- ISPR N/A
- SLRN N/A
- EPS Growth
- ISPR N/A
- SLRN N/A
- EPS
- ISPR N/A
- SLRN N/A
- Revenue
- ISPR $148,382,357.00
- SLRN N/A
- Revenue This Year
- ISPR $23.73
- SLRN N/A
- Revenue Next Year
- ISPR $75.56
- SLRN N/A
- P/E Ratio
- ISPR N/A
- SLRN N/A
- Revenue Growth
- ISPR 12.82
- SLRN N/A
- 52 Week Low
- ISPR $4.35
- SLRN $1.91
- 52 Week High
- ISPR $12.14
- SLRN $8.89
- Technical
- Relative Strength Index (RSI)
- ISPR 34.87
- SLRN 27.77
- Support Level
- ISPR $4.35
- SLRN $1.96
- Resistance Level
- ISPR $4.98
- SLRN $2.19
- Average True Range (ATR)
- ISPR 0.32
- SLRN 0.26
- MACD
- ISPR -0.02
- SLRN -0.05
- Stochastic Oscillator
- ISPR 15.61
- SLRN 3.92
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping in the United States, Europe, Canada, and South Africa.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.